26 A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Patients with Acute Exacerbation of Schizophrenia

Steven GPotkin; JelenaKunovac; Bernard LSilverman; AdamSimmons; YingJiang; LaurenDiPetrillo; DavidMcDonnell

首页> 外文期刊>CNS spectrums >26 A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Patients with Acute Exacerbation of Schizophrenia

【24h】

26 A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Patients with Acute Exacerbation of Schizophrenia

机译：26阶段3研究，以确定成年患者急性加重精神分裂症患者ALKS 3831的抗精神病药疗效和安全性

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《CNS spectrums》 |2019年第1期|共2页
作者
Steven GPotkin; JelenaKunovac; Bernard LSilverman; AdamSimmons; YingJiang; LaurenDiPetrillo; DavidMcDonnell;
展开▼
作者单位

University of California;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学与精神病学;
关键词

相似文献

外文文献
中文文献
专利

1. 26 A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Patients with Acute Exacerbation of Schizophrenia [J] . Steven GPotkin, JelenaKunovac, Bernard LSilverman, CNS spectrums . 2019,第1期

机译：26阶段3研究，以确定成年患者急性加重精神分裂症患者ALKS 3831的抗精神病药疗效和安全性
2. A Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of 3 Doses of Paliperidone Palmitate in Adults With Acutely Exacerbated Schizophrenia [J] . Gahan J. Pandina, Jean Pierre Lindenmayer, Julia Lull, Journal of clinical psychopharmacology . 2010,第3期

机译：一种随机的安慰剂对照研究，评估3剂Paliperidone棕榈酸酯的疗效和安全性患有急性加剧精神分裂症的疗效和安全性
3. A Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of 3 Doses of Paliperidone Palmitate in Adults With Acutely Exacerbated Schizophrenia [J] . Gahan J. Pandina, Jean Pierre Lindenmayer, Julia Lull, Journal of clinical psychopharmacology . 2010,第3期

机译：一种随机的安慰剂对照研究，评估3剂Paliperidone棕榈酸酯的疗效和安全性患有急性加剧精神分裂症的疗效和安全性
4. Antipsychotic medication influences cardiovascular coupling in patients suffering from acute schizophrenia [C] . Schulz Steffen, Haueisen Jens, Bar Karl-Jurgen, Computing in Cardiology Conference . 2014

机译：抗精神病药会影响急性精神分裂症患者的心血管耦合
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. F232. A PHASE 3 STUDY TO DETERMINE THE ANTIPSYCHOTIC EFFICACY AND SAFETY OF ALKS 3831 IN ADULT PATIENTS WITH ACUTE EXACERBATION OF SCHIZOPHRENIA [O] . David McDonnell, Steven G Potkin, Adam Simmons, 2018

机译：F232。确定急性加重精神分裂症成人患者止痛药3831的止痛功效和安全性的第3阶段研究
7. 26 A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Patients with Acute Exacerbation of Schizophrenia [O] . Steven G Potkin, Jelena Kunovac, Bernard L Silverman, 2019

机译：26阶段3研究，以确定成年患者急性加重精神分裂症患者ALKS 3831的抗精神病药疗效和安全性

26 A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Patients with Acute Exacerbation of Schizophrenia

著录项

引文网络

相似文献

相关主题

期刊订阅